UBS Group’s Sanaby Health Acquisition Corp. I Warrant SANBW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,470
Closed -$1K 11946
2022
Q3
$1K Hold
10,470
﹤0.01% 10245
2022
Q2
$1K Sell
10,470
-30
-0.3% -$5 ﹤0.01% 10189
2022
Q1
$2K Hold
10,500
﹤0.01% 9797
2021
Q4
$5K Buy
+10,500
New +$5.36K ﹤0.01% 9474

UBS Group's SANBW Position: Q4 2022 in Review

UBS Group sold out of Sanaby Health Acquisition Corp. I Warrant (SANBW) in Q4 2022, closing a stake of 10,470 shares — an estimated $1K sold.

UBS Group first reported a position in SANBW in Q4 2021 and held it in 4 quarters. The position peaked at $5K in Q4 2021. 0 funds tracked by Wall St. Rank hold SANBW as of Q4 2022.

  • UBS Group reported no remaining Sanaby Health Acquisition Corp. I Warrant position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 10,470 Sanaby Health Acquisition Corp. I Warrant shares in Q4 2022, an estimated $1K.
  • UBS Group first reported a position in Sanaby Health Acquisition Corp. I Warrant in Q4 2021 and held it in 4 quarters.
  • UBS Group's Sanaby Health Acquisition Corp. I Warrant position peaked at $5K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Sanaby Health Acquisition Corp. I Warrant as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.